Today is National Black HIV/AIDS Awareness Day
From POZ Magazine online… Monday, February 7, marks National Black HIV/AIDS Awareness Day (NBHAAD) 2022. By numerous measures, Black Americans are disproportionately affected by the HIV epidemic. NBHAAD highlights related challenges while raising awareness about prevention, testing, treatment and more. “This #NBHAAD we are focused on equity,” tweeted the Centers for Disease Control and Prevention’s […]
What to know about HIV and transgender men
From Medical News Today online… Most scientific studies relating to HIV and transgender people focus on transgender women — research about HIV and transgender men is limited. According to research from 2018, this is because HIV prevalence is thought to be higher among transgender women: approximately 25–31%, compared with 0–3% among transgender men. Other research, from the University […]
Study: Combining PrEP with U=U yields incredible results
From HIVplusmag.com… When people use a combination of HIV prevention methods, researchers found there was a significant drop in HIV transmission. Published in the academic journal HIV Medicine, the study found that using several methods such as taking PrEP, early HIV diagnosis from frequent testing, and proper antiretroviral treatment decreased transmission by 80 percent. The research […]
HIV & STI National Strategic Plans Call for Enhanced Coordination of Efforts
From HIV.gov… The recently released STI National Strategic Plan (STI Plan) and HIV National Strategic Plan were developed concurrently with the Viral Hepatitis National Strategic Plan and each calls for a more integrated approach to addressing the syndemic of HIV, STIs, viral hepatitis, and substance use and mental health disorders. Together, these three plans aim to enhance coordination of the activities […]
Injectable Long-Acting PrEP Is Safe, Highly Effective in Cisgender Women
From TheBodyPro.com… Injectable long-acting cabotegravir (CAB LA) has been proven safe and highly effective in preventing HIV infection among cisgender women, according to interim results from a major study announced in late January. The findings complement previously established strong results for cabotegravir-based injectable pre-exposure prophylaxis (PrEP) in cisgender men who have sex with men (MSM) […]
Mail Order Now an Option for “Ready, Set, PrEP”
From HIV.gov… The U.S. Department of Health and Human Services (HHS) recently enhanced mail-order delivery options for participants to receive PrEP HIV prevention medication at no cost to eligible individuals without prescription drug coverage. Ready, Set, PrEP participants can choose to have their PrEP medication sent directly to their home or healthcare providers (in participating states) when they enroll or continue […]
Ending the HIV Epidemic: Culturally Attuned Educational Materials for American Indians/Alaska Natives
From HIV.gov… As one of several Indian Health Service activities supported by the Minority HIV/AIDS Fund (MHAF) in Fiscal Year 2020, the Urban Indian Health Institute (UIHI) is currently leading a project focused on creating culturally attuned HIV education materials—including print, digital, and video formats—for both American Indian and Alaska Native patients and the healthcare […]
Health screening for gay men on PrEP falling behind recommended standards
From aidsmap.com… Levels of sexual health screening among gay men taking PrEP fall well below recommended levels, investigators from the United States report in the online edition of Clinical Infectious Diseases. Rates of testing for sexually transmitted infections (STIs) in the rectum and throat – which can be asymptomatic – were especially low, so too testing […]
HIV.gov: Introducing the “AHEAD” dashboard
To support the efforts of local partners in ending the HIV epidemic in their communities, the U.S. Department of Health and Human Services (HHS) is announcing the launch of a new tool, AHEAD: America’s HIV Epidemic Analysis Dashboard. What is the AHEAD Dashboard? AHEAD is a data visualization tool created to support the efforts of […]